| An Ascending Dose Study of KW-2449 in Acute Leukemias, Myelodysplastic Syndromes, and Chronic Myelogenous Leukemia (NCT00346632) | Kyowa Kirin, Inc. | 2006-06-01 |
| Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia (NCT01556386) | Seoul National University Hospital | 2006-06-01 |
| ABT-751 With Chemotherapy for Relapsed Pediatric ALL (NCT00439296) | Therapeutic Advances in Childhood Leukemia Consortium | 2006-05-22 |
| A Study of Clofarabine in Combination With Etoposide and Cyclophosphamide in Children With Acute Leukemias. (NCT00315705) | Genzyme, a Sanofi Company | 2006-03-01 |
| Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients (NCT00412243) | M.D. Anderson Cancer Center | 2006-03-01 |
| Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) (NCT00285259) | Astellas Pharma Inc | 2006-01-31 |
| Study of Immune Response Modifier in the Treatment of Hematologic Malignancies (NCT00276159) | Masonic Cancer Center, University of Minnesota | 2006-01-01 |
| Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies (NCT00270881) | Keio University | 2006-01-01 |
| Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia (NCT00723346) | ERYtech Pharma | 2006-01-01 |
| Safety and Efficacy of Imatinib Added to Chemotherapy in Treatment of Ph+ Acute Lymphoblastic Leukemia in Children (NCT00287105) | Rennes University Hospital | 2005-12-01 |
| Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic Disease (NCT00719888) | Fred Hutchinson Cancer Center | 2005-11-18 |
| Treatment of Hematologic Malignancies With Single-Unit or Double-Unit Cord Blood Transplantation (NCT00328237) | Colorado Blood Cancer Institute | 2005-11-01 |
| Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children (NCT00552825) | Sheba Medical Center | 2005-10-01 |
| Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies (NCT00143559) | St. Jude Children's Research Hospital | 2005-08-01 |
| Study to Evaluate Nilotinib in Adult Patients With Imatinib-resistant or Imatinib-intolerant Chronic Myelogenous Leukemia (CML), or Relapse/Refractory Ph+ Acute Lymphoblastic Leukemia (ALL) (Extension Study) (NCT01279473) | Novartis Pharmaceuticals | 2005-08-01 |
| Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors (NCT00664131) | St. Jude Children's Research Hospital | 2005-08-01 |
| Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL) (NCT00795886) | University of Utah | 2005-08-01 |
| Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses (NCT00192673) | Nordic Society for Pediatric Hematology and Oncology | 2005-06-01 |
| LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia (NCT00526409) | PETHEMA Foundation | 2005-06-01 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia (NCT00103285) | Children's Oncology Group | 2005-04-11 |
| DHPLC Determination of TPMT Polymorphisms. (NCT00402090) | National Institute of Cancerología | 2005-04-01 |
| Unrelated Donor Stem Cell Transplantation (NCT01364363) | Scripps Health | 2005-03-01 |
| Steroid-Induced Osteoporosis in the Pediatric Population - Canadian Incidence Study (NCT01663129) | Children's Hospital of Eastern Ontario | 2005-01-01 |
| Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic Malignancies (NCT00718757) | St. Jude Children's Research Hospital | 2005-01-01 |
| Urban Environmental Exposures and Childhood Cancer (NCT00505141) | Georgetown University | 2004-09-01 |
| Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies (NCT00513318) | University of California, San Francisco | 2004-08-01 |
| Intensified Post Remission Therapy Containing PEG-Asparaginase (NCT00184041) | University of Southern California | 2004-07-01 |
| Biology Studies of Hematologic Cancers (NCT00923442) | National Cancer Institute (NCI) | 2004-02-24 |
| Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia (NCT00075725) | Children's Oncology Group | 2003-12-29 |
| A Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic Leukaemia (NCT00930098) | Genzyme, a Sanofi Company | 2003-12-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation (NCT00144677) | Dana-Farber Cancer Institute | 2003-11-01 |
| Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00186875) | St. Jude Children's Research Hospital | 2003-11-01 |
| Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial (NCT00222027) | University Hospital, Toulouse | 2003-11-01 |
| Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 (NCT00222612) | University of Oxford | 2003-10-01 |
| Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage (NCT00890656) | M.D. Anderson Cancer Center | 2003-06-01 |
| Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant (NCT00096161) | Fred Hutchinson Cancer Center | 2003-05-01 |
| Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 (NCT01470924) | Region Örebro County | 2003-01-01 |
| Treatment of High Risk Adult Acute Lymphoblastic Leukemia (NCT00853008) | PETHEMA Foundation | 2003-01-01 |
| Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia (NCT00671658) | M.D. Anderson Cancer Center | 2002-11-01 |
| Bioequivalence Study of 6-Mercaptopurine Under Fasting Conditions (NCT00602134) | Roxane Laboratories | 2002-11-01 |
| Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic Malignancies (NCT00514722) | University of California, San Francisco | 2002-10-01 |
| Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) (NCT00130195) | Japan Adult Leukemia Study Group | 2002-09-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation (NCT00144703) | Dana-Farber Cancer Institute | 2002-07-01 |
| Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT00144963) | Acrotech Biopharma Inc. | 2002-07-01 |
| A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients. (NCT00300664) | Royal Marsden NHS Foundation Trust | 2002-07-01 |
| Glivec in Ph Positive Lymphoblastic Leukemia (NCT00388895) | PETHEMA Foundation | 2002-06-01 |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia (NCT00136435) | Dana-Farber Cancer Institute | 2002-06-01 |
| Liposomal Anthracyclin in the Treatment of Elderly ALL (NCT00600977) | French Innovative Leukemia Organisation | 2002-03-01 |
| Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia (NCT01678508) | Rigshospitalet, Denmark | 2002-01-01 |
| STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia (NCT00376467) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2001-12-01 |
| Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia (NCT00513175) | University of California, San Francisco | 2001-10-01 |
| Eligibility Screening for a NCI Pediatric Oncology Branch Research Study (NCT00026780) | National Cancer Institute (NCI) | 2001-09-24 |
| AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone (NCT00719147) | St. Jude Children's Research Hospital | 2001-07-01 |
| LAL-BR/2001: Study Treatment to Low Risk ALL (NCT00526175) | PETHEMA Foundation | 2001-06-01 |
| Treatment of Acute Lymphoblastic Leukemia in Children (NCT00165178) | Dana-Farber Cancer Institute | 2000-09-01 |
| Treatment of Adult ALL With an MRD-directed Programme. (NCT00358072) | Northern Italy Leukemia Group | 2000-05-01 |
| T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts (NCT00368355) | Baylor College of Medicine | 2000-04-01 |
| Learning Impairments Among Survivors of Childhood Cancer (NCT00576472) | St. Jude Children's Research Hospital | 2000-01-01 |
| LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive (NCT00526305) | PETHEMA Foundation | 2000-01-01 |
| An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia (NCT00171249) | Novartis Pharmaceuticals | 1999-08-09 |
| Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow (NCT00003838) | National Heart, Lung, and Blood Institute (NHLBI) | 1999-04-15 |
| Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia (NCT00003861) | Alliance for Clinical Trials in Oncology | 1999-04-01 |
| Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia (NCT00187005) | St. Jude Children's Research Hospital | 1998-07-01 |
| A Study of Children With Refractory or Relapsed ALL (NCT00187083) | St. Jude Children's Research Hospital | 1997-02-01 |
| GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL. (NCT00439920) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 1996-10-01 |
| PETHEMA LAL-RI/96: Treatment for Patients With Standard Risk Acute Lymphoblastic Leukemia (NCT00494897) | PETHEMA Foundation | 1996-06-01 |
| Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) (NCT00015587) | National Institute of Environmental Health Sciences (NIEHS) | 1995-04-01 |
| Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia (NCT00411541) | International BFM Study Group | 1995-04-01 |
| Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel (NCT05776134) | Kite, A Gilead Company | |
| JZP458 - Recombinant Erwinia Asparaginase for Treatment of ALL / LBL Patients With Hypersensitivity to E. Coli-derived Asparaginase (NCT04943952) | Jazz Pharmaceuticals | |
| Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant (NCT01200017) | Christopher Dvorak | |
| Cardiometabolic Status in Childhood Acute Lymphoblastic Leukemia (NCT01688752) | University of Minnesota | |
| Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety Switch (NCT03594162) | UNC Lineberger Comprehensive Cancer Center | |
| Expanded Access Program: Safety of Erythrocytes Encapsulating L-asparaginase (GRASPA®) in Combination With Polychemotherapy in Patients Under 55 Years Old With Acute Lymphoblastic Leukemia (ALL) at Risk to Receive Other Formulation of Asparaginase (NCT02197650) | ERYtech Pharma | |